Position in ATHE
as of Sep 30, 2026
· filed Oct 8, 2026
Position Value
$5,204
-$7,195 QoQ
Shares Held
1,426
-38.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 3 holders
Holding Since
Dec 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATHE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Sep 30, 2026GAMMA Investing LLC holds $25,084,515 across 307 Biotechnology names. ATHE ranks #184 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,569 | $3,957,148 | |
| 2 | MRNA |
Moderna, Inc.
|
16,136 | $3,107,309 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,306 | $1,748,570 | |
| 4 | INCY |
Incyte Corp
|
8,598 | $1,043,367 | |
| 5 | TECH |
BIO-TECHNE Corp
|
12,226 | $886,018 | |
| 6 | EXEL |
Exelixis, Inc.
|
12,227 | $714,179 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
17,791 | $650,616 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
5,609 | $646,325 |
All Filings in ATHE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-09-30 | $5,204 | 1,426 | Shares | Defined | 2026-10-08 | |
| 2026-06-30 | $12,399 | 2,309 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | $6,458 | 1,856 | Shares | Defined | 2026-04-06 | |
| 2025-12-31 | $2,433 | 790 | Shares | Defined | 2026-01-05 | |
| No filing history on record for this holder in this stock. | ||||||